Date Filed | Type | Description |
07/13/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
04/13/2022 |
4
| BALL BRYAN (Chief Qual. Officer & SVP Ops.) has filed a Form 4 on INTERCEPT PHARMACEUTICALS, INC.
Txns:
| Paid exercise price by delivering 531 shares
@ $17.19, valued at
$9.1k
|
|
01/31/2022 |
4
| BALL BRYAN (Chief Qual. Officer & SVP Ops.) has filed a Form 4 on INTERCEPT PHARMACEUTICALS, INC.
Txns:
| Granted 3,600 shares
@ $0 Granted 6,100 options to buy
@ $14.44, valued at
$88.1k
|
|
01/13/2022 |
4
| BALL BRYAN (Chief Qual. Officer & SVP Ops.) has filed a Form 4 on INTERCEPT PHARMACEUTICALS, INC.
Txns:
| Paid exercise price by delivering 2,455 shares
@ $16.83, valued at
$41.3k
|
|
01/11/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
01/11/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
10/23/2020 |
4
| BALL BRYAN (Chief Quality Officer) has filed a Form 4 on IMMUNOMEDICS INC
Txns:
| Disposed/sold 10,000 shares
@ $0 Disposed/sold 261,937 options to buy
@ $0 |
|
03/05/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
10/03/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
09/10/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/21/2019 |
4
| BALL BRYAN (Chief Quality Officer) has filed a Form 4 on IMMUNOMEDICS INC
Txns:
| Bought 5,000 shares
@ $13.35, valued at
$66.8k
|
|
03/07/2019 |
4
| BALL BRYAN (Chief Quality Officer) has filed a Form 4 on IMMUNOMEDICS INC
Txns:
| Granted 142,857 options to buy
@ $16.96, valued at
$2.4M
|
|
03/07/2019 |
3
| BALL BRYAN (Chief Quality Officer) has filed a Form 3 on IMMUNOMEDICS INC |